RTW INVESTMENTS, LP Q4 2021 Filing

Filed February 14, 2022

Portfolio Value

$6.8B

Holdings

124

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (124 positions)

#	Stock	Shares	Value	% Portfolio
101	—ASLAN PHARMACEUTICALS LTD	3,250,000	$3.6M	0.05%
102	—ISOPLEXIS CORP	365,000	$3.4M	0.05%
103	—MEDICUS SCIENCES ACQUISITION	300,000	$2.9M	0.04%
104	MXCTGBXMAXCYTE INC	275,000	$2.8M	0.04%
105	—POINT BIOPHARMA GLOBAL INC	490,000	$2.7M	0.04%
106	CNTBCONNECT BIOPHARMA HLDGS LTD	450,000	$2.3M	0.03%
107	—APOLLO ENDOSURGERY INC	258,064	$2.2M	0.03%
108	DNAYCODEX DNA INC	200,000	$2.2M	0.03%
109	TNGXTANGO THERAPEUTICS INC	180,819	$2.0M	0.03%
110	—MINK THERAPEUTICS INC	416,666	$1.9M	0.03%
111	MDXGMIMEDX GROUP INC	295,748	$1.8M	0.03%
112	SMFRUSDSEMA4 HOLDINGS CORP	400,000	$1.8M	0.03%
113	RXSTRXSIGHT INC	150,000	$1.7M	0.02%
114	—AKOYA BIOSCIENCES INC	100,000	$1.5M	0.02%
115	—MIROMATRIX MED INC	280,000	$1.3M	0.02%
116	RCELAVITA MEDICAL INC	106,667	$1.3M	0.02%
117	—SINGULAR GENOMICS SYSTEMS IN	100,000	$1.2M	0.02%
118	MASS908 DEVICES INC	40,000	$1.0M	0.02%
119	—MINERVA SURGICAL INC	166,000	$853K	0.01%
120	BOLT1EURBOLT BIOTHERAPEUTICS INC	126,365	$619K	0.01%
121	—ZYMERGEN INC	70,000	$468K	0.01%
122	—RENOVACOR INC	350,000	$200K	0.00%
123	698ACHILLES THERAPEUTICS PLC	12,229	$61K	0.00%
124	—MEDICUS SCIENCES ACQUISITION	33,331	$24K	0.00%

PreviousPage 2 of 2